earnings
confidence high
sentiment neutral
materiality 0.75
Surgery Partners Q1 revenue up 11.7% to $666.2M, net loss $24.9M, raises 2023 EBITDA guidance >$430M
Surgery Partners, Inc.
2023-Q1 EPS reported
-$0.20
revenue$666,200,000
- Revenue $666.2M (+11.7% YoY); same-facility revenue +10.3% (cases +5.3%, revenue per case +4.8%).
- Net loss attributable to SGRY $24.9M vs net income $12.2M in Q1 2022; Adjusted EBITDA $90.1M (+17% from $77.1M).
- Raises 2023 Adjusted EBITDA guidance to >$430M; Q1 free cash flow $20.5M, deployed $60M on five acquisitions.
- New strategic partnerships with Intermountain Health and OhioHealth for expansion in new markets.
- Net debt to EBITDA 4.3x; liquidity ~$800M ($245.5M cash + $545.9M revolver availability).